Cadila Healthcare shares up 4% on completion of phase-II trial of COVID vaccine

Based upon the results from its Phase 2 study, Zydus Cadila now plans to conduct a Phase 3 clinical trial in India.

Read Full Story on MoneyControl

Enter your email address:


We will be happy to hear your thoughts

Leave a reply

IndiaClicking - Buzzing News & Stocks